dc.contributor.author | Ceylan, Cavit | |
dc.contributor.author | Tonyali, Şenol | |
dc.contributor.author | Akdogan, Meral | |
dc.contributor.author | Bostanci, Erdal Birol | |
dc.contributor.author | Akoglu, Musa | |
dc.contributor.author | Aksoy, Erol | |
dc.contributor.author | Sobaci, Erdem | |
dc.date.accessioned | 2021-03-04T17:32:34Z | |
dc.date.available | 2021-03-04T17:32:34Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Tonyali Ş., Aksoy E., Sobaci E., Akdogan M., Ceylan C., Bostanci E. B. , Akoglu M., "Is Serum Prostate-Specific Antigen a Reliable Prostate Cancer Marker in Liver Transplant Candidates", EXPERIMENTAL AND CLINICAL TRANSPLANTATION, cilt.17, sa.4, ss.536-539, 2019 | |
dc.identifier.issn | 1304-0855 | |
dc.identifier.other | av_86460cb0-4191-48c9-b440-97870ebcf74c | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/91239 | |
dc.identifier.uri | https://doi.org/10.6002/ect.2017.0259 | |
dc.description.abstract | Objectives: In this study, we aimed to determine whether the prostate-specific antigen level is a reliable marker of prostate cancer in patients with hepatic insufficiency, based on evaluation of alterations in serum prostate-specific antigen levels after liver transplant in patients with hepatic insufficiency. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TRANSPLANTASYON | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | Is Serum Prostate-Specific Antigen a Reliable Prostate Cancer Marker in Liver Transplant Candidates | |
dc.type | Makale | |
dc.relation.journal | EXPERIMENTAL AND CLINICAL TRANSPLANTATION | |
dc.contributor.department | Turkey Specialized Higher Education & Research Hospital , , | |
dc.identifier.volume | 17 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 536 | |
dc.identifier.endpage | 539 | |
dc.contributor.firstauthorID | 345894 | |